NCT00536796View on ClinicalTrials.gov

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

CompletedOBSERVATIONAL

Enrollment

1,096

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

HyperlipidemiasAtherosclerosisCoronary Heart DiseaseCarotid StenosisPeripheral Vascular DiseasesDiabetes Mellitus

Trial Locations (1)

Unknown

Research Site, Rohrbach

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY